Cargando…

TERT promoter mutations and monoallelic activation of TERT in cancer

Here we report that promoter mutations in telomerase (TERT), the most common noncoding mutations in cancer, give rise to monoallelic expression of TERT. Through deep RNA sequencing, we find that TERT activation in human cancer cell lines can occur in either mono- or biallelic manner. Without excepti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, F W, Bielski, C M, Rinne, M L, Hahn, W C, Sellers, W R, Stegmeier, F, Garraway, L A, Kryukov, G V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688396/ https://www.ncbi.nlm.nih.gov/pubmed/26657580 http://dx.doi.org/10.1038/oncsis.2015.39

Ejemplares similares

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
por: Griewank, K G, et al.
Publicado: (2013)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

The Solo Play of TERT Promoter Mutations
por: Hafezi, François, et al.
Publicado: (2020)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
por: Salgado, Catarina, et al.
Publicado: (2020)

Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations
por: FUJIO, Shingo, et al.
Publicado: (2021)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015)

The synthesis of deuteriated tri‐tert‐butyl phosphine
por: Brown, Lucy C., et al.
Publicado: (2022)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
por: Panebianco, Federica, et al.
Publicado: (2019)

Crystal structure of (E)-2-(tert-butylamino)-4-(tert-butylimino)naphthalen-1(4H)-one
por: Lamoureux, Guy, et al.
Publicado: (2018)

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

Pathogenic TERT promoter variants in telomere diseases
por: Gutierrez-Rodrigues, Fernanda, et al.
Publicado: (2018)

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
por: Gupta, Sounak, et al.
Publicado: (2021)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas
por: Mellai, Marta, et al.
Publicado: (2021)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
por: Labussière, M, et al.
Publicado: (2014)

Cancer-associated TERT promoter mutations abrogate telomerase silencing
por: Chiba, Kunitoshi, et al.
Publicado: (2015)

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)

Targeted Long-Read Bisulfite Sequencing Identifies Differences in the TERT Promoter Methylation Profiles between TERT Wild-Type and TERT Mutant Cancer Cells
por: Lee, Seungjae, et al.
Publicado: (2022)

Unexpected Isomerization of Hexa‐tert‐butyl‐octaphosphane
por: Grell, Toni, et al.
Publicado: (2019)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

TERT Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract
por: Taylor, Alexander S., et al.
Publicado: (2022)

Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation
por: Wijnenga, Maarten M J, et al.
Publicado: (2023)

Promoter CpG methylation inhibits Krüppel-like factor 2 (KLF2)-Mediated repression of hTERT gene expression in human T-cells
por: Mizuguchi, Mariko, et al.
Publicado: (2021)

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
por: Zvereva, Maria, et al.
Publicado: (2020)

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

Absence of TERT promoter mutations in colorectal precursor lesions and cancer
por: Cruvinel-Carloni, Adriana, et al.
Publicado: (2018)

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk
por: Osella-Abate, Simona, et al.
Publicado: (2019)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_31m0n5g4e1ifiksmh06rbvb0t2